Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Grove Announces Third Quarter 2025 Financial Results
-
Animated Musical DAVID Earns Nearly $3 Million in Theatrical Presales in Three Weeks – Highest in Angel’s History
-
SentinelOne Announces Date of Fiscal Third Quarter 2026 Financial Results Conference Call and Participation in Upcoming Investor Conference
-
Coursera to Hold Virtual Chat with Chief Executive Officer Greg Hart
-
Figure Technology Solutions Reports Third Quarter 2025 Results
-
Acrivon Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
-
MediaAlpha Appoints Insurance Industry Veteran Ramon Jones to Board of Directors
-
ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates
-
GameSquare Holdings Reports 2025 Third Quarter Results
-
TSS Strengthens AI and High-Performance Computing Strategy with Appointment of Technology Industry Veteran Vivek Mohindra to Board of Directors
-
TEAMSTERS-BACKED DELIVERY PROTECTION ACT SECURES SUPERMAJORITY IN NEW YORK CITY COUNCIL
-
CSE Bulletin: Symbol Change - World Blockchain Corp. (CK)
-
Fennec Pharmaceuticals Announces Proposed Offering of Common Shares
-
Sable Offshore Corp. Reports Third Quarter 2025 Financial Results
-
Verastem Oncology Announces Proposed Public Offering of Common Stock
-
BioHarvest Sciences Reports Third Quarter 2025 Financial Results
-
Akanda Researching Security Requirements for Full Cultivation License
-
BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025
-
Urbana Corporation Has Filed 2025 Third Quarter Interim Financial Statements
-
Newsmax Announces Third Quarter 2025 Financial Results
-
A2Z Cust2Mate Solutions Corp. Announces Q3 2025 Financial Results Highlighting Strong Balance Sheet and Continued Growth
-
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
-
First Watch Restaurant Group, Inc. to Participate at the Stephens Annual Investment Conference on November 18-19, 2025
-
PacBio to Present at Upcoming Investor Conferences
-
Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis
-
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
-
BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
-
Birchtech Reports Third Quarter 2025 Financial Results
-
Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
-
Hudson Technologies Appoints Kenneth Gaglione as Chairman of the Board, President and Chief Executive Officer
-
STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
-
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
-
Manulife President and Chief Executive Officer Phil Witherington to participate in fireside chat with TD Securities
-
SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results
-
RBC Global Asset Management announces leadership transition: Stu Kedwell to be appointed as Global Chief Investment Officer
-
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Genpact Limited Announces Pricing of 4.950% Senior Notes due 2030 by Genpact UK Finco plc and Genpact USA, Inc.
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
-
WhiteFiber, Inc. Reports Third Quarter 2025 Results
-
Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
Precigen Reports Third Quarter 2025 Financial Results and Business Updates
-
Evolv Technology Reports Third Quarter Financial Results
-
Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M
-
Research Solutions Reports First Quarter Fiscal Year 2026 Results
-
Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update
-
Starz Entertainment Corp. Reports Results for the Third Quarter Ended September 30, 2025
-
Blaize Announces Third Quarter 2025 Financial Results

